New specialized models offer support for Jupiter's ControlPoint TM display wall management software, Jupiter Canvas collaborative visualization solutions, and HDCP-protected content Jupiter is showing three new products at Integrated Systems ... CNBC, 2 weeks ago
1 images for "fusion fc"
Heat Biologics Inc presents positive preclinical data on novel approach to combination immunotherapy at keystone symposia on tumor immunology
8:00am EST Heat Biologics Inc:Says presentation of data demonstrating incorporation of T-cell costimulatory fusion proteins into Heat's gp96-Ig vaccine platform, at a Keystone Symposia on Tumor Immunology -- Multidisciplinary Science Driving ...Reuters, 2 weeks ago Heat Biologics : Presents Positive Preclinical Data on a Novel Approach to Combination Immunotherapy at the Keystone Symposia on Tumor Immunology 4 Traders, 1 week ago Heat Biologics Presents Positive Preclinical Data on a Novel Approach to Combination Immunotherapy at the Keystone Symposia on Tumor Immunology RCL Advisors, 2 weeks ago
Disclosed are antibody fusion proteins with a modified FcRn binding site and nucleic acid molecules encoding them. The antibody fusion protein include two polypeptide chains, wherein the first polypeptide chain includes a biologically active ...PharmCast, 2 months ago Neutralizing antibodies against GDF-8 and uses therefor PharmCast, 2 weeks ago Anti-fXI antibodies and methods of use PharmCast, 2 weeks ago Humanization of rabbit antibodies using a universal antibody framework PharmCast, 3 weeks ago
Biogen Idec : Findings from Biogen Idec, Inc. in the Area of Fusion Proteins Described (A single chain variant of factor VIII Fc fusion protein retains normal in...
Findings from Biogen Idec, Inc. in the Area of Fusion Proteins Described (A single chain variant of factor VIII Fc fusion protein retains normal in vivo efficacy but exhibits altered in vitro activity) By a News Reporter-Staff News Editor at ...4 Traders, 1 month ago Biogen Idec spotlights Eloctate manufacturing in video targeted at consumers FiercePharmaManufacturing, 4 weeks ago Biogen Idec : Researchers' Work from Biogen Idec, Inc. Focuses on Immunoproteins (Evaluation of a Novel Methacrylate-Based Protein A Resin for the Purification of... 4 Traders, 2 months ago
Ventura County Fusion News Release - www.vcfusion.com Wednesday, January 14, 2015 VENTURA, Calif. - The Ventura County Fusion are pleased to announce their first game of 2015, an exhibition match against Sacramento Republic FC on Monday, ...Noodls, 1 month ago
This disclosure relates to compositions capable of use in the treatment of spinal cord injuries and related disorders of the central nervous system (CNS), and in particular, compositions including proteoglycan degrading molecules and compositions ...PharmCast, 2 months ago
SAN FRANCISCO The recombinant fusion protein luspatercept increased hemoglobin levels in patients with nontransfusion-dependent beta-thalassemia, according to study results presented at the ASH Annual Meeting and Exposition . Luspatercept ...Orthopedics Today, 2 months ago
Provided are a fusion protein of Exendin-4 and its analog, the preparation method and use thereof. The fusion protein is obtained by fusing of Exendin-4 or its analog to Fc region of human IgG2 via a linking peptide, which has the better stability ...PharmCast, 2 months ago
Biogen Idec And Swedish Orphan Biovitrum Announce Positive Top-Line Efficacy And Safety Results From Phase 3 ALPROLIX Pediatric Study
-Study Meets Primary Endpoint and Achieves Low Bleeding Rates with Once-Weekly Prophylactic Dosing in Children - - Results Support EU Regulatory Submission and Future Pediatric Indication Applications- CAMBRIDGE, Mass. & STOCKHOLM--(BUSINESS ...BioSpace, 4 hours ago Biogen Idec and Sobi Announce Positive Top-Line Efficacy and Safety Results from Phase 3 ALPROLIX® Pediatric Study CNBC, 10 hours ago Press Release: Biogen Idec and Sobi announce positive top-line efficacy and safety results from phase 3 Alprolix(R) paediatric study iMarketReports, 10 hours ago REG-Biogen Idec and Sobi announce positive top-line efficacy and safety results from phase 3 Alprolix(R) paediatric study Reuters, 10 hours ago
Details Category: Antibodies Published on Thursday, 26 February 2015 16:04 Hits: 24 BERLIN, Germany I February 26, 2015 I Bayer HealthCare announced today that EYLEA® (aflibercept solution for injection into the eye) has been approved by the ...PipelineReview, 1 day ago Bayer's aflibercept solution for injection gets recommendation for approval in EU Pharmaceutical Business Review, 1 month ago Bayer Receives Recommendation for Approval for New Treatment Option with Aflibercept Solution for Injection in EU PipelineReview, 1 month ago
on your WebpageAdd Widget >Get your members hooked!